Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohua Ding

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Chronic Diseases and Translational Medicine|May 27, 2022
Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trailNan Chen, Changying Xing, Jianying Niu, et al.
JAMA Network Open|March 14, 2025
Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical TrialZheyi Dong, Ping Luo, Shiren Sun, et al.
Blood Purification|August 11, 2022
Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic PruritusDelong Zhao, Yuanda Wang, Yong Wang, et al.
Journal of the American Society of Nephrology : JASN|July 30, 2017
Association Analysis of the MHC in Lupus NephritisRicong Xu, Qibin Li, Rongjun Liu, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Chronic Diseases and Translational Medicine|May 27, 2022
Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trailNan Chen, Changying Xing, Jianying Niu, et al.
JAMA Network Open|March 14, 2025
Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical TrialZheyi Dong, Ping Luo, Shiren Sun, et al.
Blood Purification|August 11, 2022
Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic PruritusDelong Zhao, Yuanda Wang, Yong Wang, et al.
Journal of the American Society of Nephrology : JASN|July 30, 2017
Association Analysis of the MHC in Lupus NephritisRicong Xu, Qibin Li, Rongjun Liu, et al.
Pageof 16